• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency.

作者信息

Toskov Vasil, Bali Pawan, Hershfield Michael S, Ehl Stephan, Speckmann Carsten

机构信息

Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Department of Medicine and Biochemistry, Duke University Medical Center, Durham, NC, USA.

出版信息

J Clin Immunol. 2024 Sep 12;45(1):8. doi: 10.1007/s10875-024-01794-7.

DOI:10.1007/s10875-024-01794-7
PMID:39264481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11393103/
Abstract
摘要

相似文献

1
Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency.迟发性腺苷脱氨酶缺乏症患者的长期酶替代疗法成功案例
J Clin Immunol. 2024 Sep 12;45(1):8. doi: 10.1007/s10875-024-01794-7.
2
ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.ADA 缺乏症：临床和实验室特征及转归评估。
J Clin Immunol. 2018 May;38(4):484-493. doi: 10.1007/s10875-018-0496-9. Epub 2018 May 9.
3
Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency.奥门综合征可发生于腺苷脱氨酶缺乏症的酶替代治疗过程中。
J Clin Immunol. 2024 Jul 15;44(7):162. doi: 10.1007/s10875-024-01764-z.
4
Effects of enzyme replacement therapy on immune function in ADA deficiency patient.酶替代疗法对腺苷脱氨酶缺乏症患者免疫功能的影响。
Clin Immunol. 2015 Dec;161(2):391-3. doi: 10.1016/j.clim.2015.06.011. Epub 2015 Jun 27.
5
Management of ADA-Deficient SCID Patient on Adagen During Pregnancy.孕期使用阿糖苷酶α治疗腺苷脱氨酶缺乏性重症联合免疫缺陷病患者的管理
J Clin Immunol. 2019 Nov;39(8):846-848. doi: 10.1007/s10875-019-00692-7. Epub 2019 Oct 16.
6
Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.腺苷脱氨酶缺乏症患者的长期预后：单中心经验。
J Clin Immunol. 2017 Aug;37(6):582-591. doi: 10.1007/s10875-017-0421-7. Epub 2017 Jul 26.
7
Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy.3例腺苷脱氨酶缺乏症患者长期酶替代治疗的结果。
Ann Allergy Asthma Immunol. 2021 May;126(5):593-595. doi: 10.1016/j.anai.2020.12.008. Epub 2021 Jan 30.
8
Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.两名接受无细胞减灭预处理的干细胞基因治疗的日本腺苷脱氨酶缺乏症患者的结果。
J Clin Immunol. 2015 May;35(4):384-98. doi: 10.1007/s10875-015-0157-1. Epub 2015 Apr 15.
9
Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.腺苷脱氨酶缺乏症患者的诊断、治疗及长期随访：单中心经验
J Clin Immunol. 2015 Oct;35(7):624-37. doi: 10.1007/s10875-015-0191-z. Epub 2015 Sep 16.
10
A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.对一名腺苷脱氨酶缺乏患者进行的24年酶替代疗法
Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2169. Epub 2015 Dec 18.

本文引用的文献

1
Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study.腺苷脱氨酶缺乏症患者使用依拉糖苷酶的安全性和有效性：一项多中心、开放标签、单臂、3 期和上市后临床研究。
Immun Inflamm Dis. 2023 Jul;11(7):e917. doi: 10.1002/iid3.917.
2
Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A Real-World Experience.ADA 缺陷患者接受 Elapegademase 治疗的长期免疫重建：真实世界经验。
J Allergy Clin Immunol Pract. 2023 Jun;11(6):1725-1733. doi: 10.1016/j.jaip.2023.01.028. Epub 2023 Feb 1.
3
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
ADA 缺陷型严重联合免疫缺陷症治疗后的结果：PIDTC 的报告。
Blood. 2022 Aug 18;140(7):685-705. doi: 10.1182/blood.2022016196.
4
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.青少年和成人遗传性免疫缺陷患者的造血干细胞移植：一项欧洲血液与骨髓移植学会免疫缺陷工作组的研究
Blood. 2022 Oct 6;140(14):1635-1649. doi: 10.1182/blood.2022015506.
5
Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy.3例腺苷脱氨酶缺乏症患者长期酶替代治疗的结果。
Ann Allergy Asthma Immunol. 2021 May;126(5):593-595. doi: 10.1016/j.anai.2020.12.008. Epub 2021 Jan 30.
6
Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy.腺苷脱氨酶缺乏症患者接受酶替代治疗 27 年期间的发病率。
Clin Immunol. 2020 Feb;211:108321. doi: 10.1016/j.clim.2019.108321. Epub 2019 Dec 5.
7
Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis.迟发性腺苷脱氨酶缺乏症：早期诊断策略
J Allergy Clin Immunol. 2012 Oct;130(4):991-4. doi: 10.1016/j.jaci.2012.04.004. Epub 2012 May 10.
8
Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.不典型严重联合免疫缺陷患者的临床和免疫学表现。
Clin Immunol. 2011 Oct;141(1):73-82. doi: 10.1016/j.clim.2011.05.007. Epub 2011 May 30.
9
Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).腺苷脱氨酶（ADA）缺乏的重症联合免疫缺陷（SCID）的酶替代疗法的长期疗效。
Clin Immunol. 2005 Nov;117(2):133-43. doi: 10.1016/j.clim.2005.07.006. Epub 2005 Aug 22.
10
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.儿童期血液淋巴细胞的免疫表型分析。淋巴细胞亚群的参考值。
J Pediatr. 1997 Mar;130(3):388-93. doi: 10.1016/s0022-3476(97)70200-2.